Horizon Blue Cross and Blue Shield of New Jersey policies, page 9

Search Horizon Blue Cross and Blue Shield of New Jersey's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

834 public policies Substrate tracks for Horizon Blue Cross and Blue Shield of New Jersey, by title.

Horizon Blue Cross and Blue Shield of New Jersey policies
PolicyDetailsCodesSource
Infliximab (Remicade), infliximab-dyyb (Inflectra), and infliximab-abda (Renflexis), infliximab-qbtx (Ixifi), and infliximab-axxq (Avsola)Commercial—Original policy ↗
Ingestible pH and Pressure CapsuleCommercial, Medicaid—Original policy ↗
Inhaled Nitric OxideCommercial, Medicaid—Original policy ↗
Injectable Antiemetic Agents [Dolasetron (Anzemet), Granisetron (Kytril, Sustol), Ondansetron (Zofran), Palonosetron (Aloxi), Rolapitant (Varubi), Aprepitant (Cinvanti), Fosaprepitant (Emend), and Fosnetupitant/Palonosetron (Akynzeo), Amisulpride (Barhemsys)]Commercial—Original policy ↗
Injectable Bulking Agents for the Treatment of Urinary IncontinenceCommercial, Medicaid1Original policy ↗
Inotuzumab Ozogamicin (Besponsa)Commercial—Original policy ↗
Inpatient ReadmissionEffective Dec 2, 2024 · Commercial—Original policy ↗
Insulin Infusion PumpsCommercial, Medicaid—Original policy ↗
Insulin Potentiation TherapyCommercial, Medicaid—Original policy ↗
Interferential Current StimulationCommercial, Medicaid—Original policy ↗
Intermittent Pneumatic or Mechanical Compression Devices for Peripheral Artery DiseaseCommercial, Medicaid—Original policy ↗
Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)Commercial—Original policy ↗
Interspinous Fixation (Fusion) DevicesCommercial—Original policy ↗
Interventions for Progressive ScoliosisMedicaid2Original policy ↗
Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the BrainCommercial, Medicaid—Original policy ↗
Intracellular Micronutrient AnalysisCommercial, Medicaid1Original policy ↗
Intradialytic Parenteral NutritionCommercial, Medicaid—Original policy ↗
Intranasal Influenza Virus Vaccine (FluMist Quadrivalent)Commercial1Original policy ↗
Intraocular Radiation Therapy for Age-Related Macular DegenerationCommercial—Original policy ↗
Intraoperative Neurophysiologic MonitoringCommercial—Original policy ↗
Intravenous Anesthetics for the Management of Chronic Pain and DepressionCommercial—Original policy ↗
Intravenous Antibiotic Therapy for Lyme DiseaseCommercial, Medicaid—Original policy ↗
Intravenous Drug Therapy for Multiple SclerosisCommercial2Original policy ↗
Intravenous Immunoglobulin (IVIG) TherapyCommercial—Original policy ↗
Intravenous/Intramuscular Vitamin and/or Mineral TherapyCommercial, Medicaid—Original policy ↗
Intravesical Transurethral Electrical Bladder Stimulation (ITEBS)Commercial, Medicaid—Original policy ↗
Intravitreal and Punctum Corticosteroid ImplantsCommercial, Medicaid—Original policy ↗
Invasive Prenatal (Fetal) Diagnostic TestingCommercial, Medicaid2Original policy ↗
Ipilimumab (Yervoy)Commercial—Original policy ↗
Isatuximab-irfc (Sarclisa)Commercial—Original policy ↗
Islet TransplantationEffective Jun 10, 2019 · Commercial, Medicaid—Original policy ↗
Isolated Limb Perfusion/Isolated Limb Infusion for Malignant MelanomaCommercial, Medicaid—Original policy ↗
Isolated Small Bowel TransplantCommercial, Medicaid—Original policy ↗
Ixabepilone (Ixempra)—Original policy ↗
JAK2, MPL, and CALR Testing for Myeloproliferative NeoplasmsCommercial, Medicaid2Original policy ↗
KeratoprosthesisCommercial—Original policy ↗
Ketogenic DietCommercial, Medicaid—Original policy ↗
Kidney Transplant—Original policy ↗
KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin TherapyEffective Aug 1, 2017 · Commercial—Original policy ↗
Knee BracesCommercial, Medicaid23Original policy ↗
KRAS, NRAS, and BRAF Variant Analysis in Metastatic Colorectal CancerCommercial, Medicaid5Original policy ↗
Lab Panel RebundlingEffective Mar 1, 2012 · Commercial, Medicaid—Original policy ↗
Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients With CancerCommercial—Original policy ↗
Laboratory Services Billed by PhysiciansEffective Feb 25, 2019 · Commercial, Medicaid3Original policy ↗
Laboratory Tests for Heart and Kidney Transplant RejectionCommercial1Original policy ↗
LaminectomyCommercial—Original policy ↗
Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids—Original policy ↗
Laronidase (Aldurazyme), Galsulfase (Naglazyme), and Idursulfase (Elaprase), Elosulfase alfa (Vimizim), and Vestronidase alfa (Mepsevii)Commercial—Original policy ↗
Laser Treatment of OnychomycosisCommercial, Medicaid—Original policy ↗
Laser Treatment of Psoriasis or ParapsoriasisEffective Jan 24, 2022 · Commercial3Original policy ↗

Back to Horizon Blue Cross and Blue Shield of New Jersey

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.